CLN6 Mutation in a Patient with Progressive Myoclonus Epilepsy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neuronal ceroid lipofuscinoses (NCLs) are inherited neurodegenerative disorders, which are caused by the accumulation of lipopigment in lysosomes. Variant forms of late infantile NCLs (vLINCLs) characterized by a later onset of seizures and visual impairment (3–8 years) than in the classic form (2–4 years) are caused by mutations of the gene encoding ceroid lipofuscinosis neuronal protein 6 (CLN6). In a girl with progressive myoclonus epilepsy, we found heterozygous variants of CLN6 (NM_ 017882.2; NP_060352.1): c.296A>G (p.Lys99Arg) and c.307C>T (p.Arg103Trp). They were identified with whole-exome sequencing and verified with Sanger sequencing. At 7 years and 9 months, our patient had developed multiple types of seizures, prominent myoclonus with photosensitivity, regression in motor and language skills, pyramidal and extrapyramidal signs, and brain atrophy in brain images, all of which were progressive and were compatible with vLINCLs. However, this first Korean report shows no visual impairment, which resembles the previously reported Japanese case.
Abstract
Neuronal ceroid lipofuscinoses (NCLs) are inherited neurodegenerative disorders, which are caused by the accumulation of lipopigment in lysosomes. Variant forms of late infantile NCLs (vLINCLs) characterized by a later onset of seizures and visual impairment (3–8 years) than in the classic form (2–4 years) are caused by mutations of the gene encoding ceroid lipofuscinosis neuronal protein 6 (CLN6). In a girl with progressive myoclonus epilepsy, we found heterozygous variants of CLN6 (NM_ 017882.2; NP_060352.1): c.296A>G (p.Lys99Arg) and c.307C>T (p.Arg103Trp). They were identified with whole-exome sequencing and verified with Sanger sequencing. At 7 years and 9 months, our patient had developed multiple types of seizures, prominent myoclonus with photosensitivity, regression in motor and language skills, pyramidal and extrapyramidal signs, and brain atrophy in brain images, all of which were progressive and were compatible with vLINCLs. However, this first Korean report shows no visual impairment, which resembles the previously reported Japanese case.
참고문헌 (11)
- De Siqueira LF, "Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects", J Neurol, 257, pp.1612~1619 (2010)[DOI]
- Kousi M, "Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses", Hum Mutat, 33, pp.42~63 (2012)[DOI]
- Jalanko A, "Neuronal ceroid lipofuscinoses", Biochim Biophys Acta, 1793, pp.697~709 (2009)[DOI]
- Mole SE, "Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses", Neurogenetics, 6, pp.107~126 (2005)[DOI]
- Canafoglia L, "Electroclinical spectrum of the neuronal ceroid lipofuscinoses associated with CLN6 mutations", Neurology, 85, pp.316~324 (2015)[DOI]
- Gao H, "Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse", Am J Hum Genet, 70, pp.324~335 (2002)[DOI]
- Sharp JD, "Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis", Hum Mutat, 22, pp.35~42 (2003)[DOI]
- Sato R, "First Japanese variant of late infantile neuronal ceroid lipofuscinosis caused by novel CLN6 mutations", Brain Dev, 38, pp.852~856 (2016)[DOI]
- Arsov T, "Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6", Am J Hum Genet, 88, pp.566~573 (2011)[DOI]
- Pena JA, "Serial MRI findings in the Costa Rican variant of neuronal ceroidlipofuscinosis", Pediatr Neurol, 25, pp.78~80 (2001)[DOI]
- Cismondi IA, "Gene symbol: CNL6. Disease: Neuronal ceroid lipofuscinosis, late Infantile", Hum Genet, 124, pp.324~ (2008)